Gaush Meditech Ltd., a company incorporated in the Cayman Islands, announced that its subsidiary, Gaush Neotech Ltd., has obtained a medical device registration certificate from the Jiangsu Medical Products Administration for its newly developed "frequency-domain biometer." This innovative device, designed with a dual-optical-path and based on a new-generation frequency-domain measurement principle, offers enhanced resolution, faster imaging speed, and improved signal-to-noise ratio compared to traditional biometers. This development is particularly significant in addressing the growing market demand for myopia prevention and control in China, where the myopia rate among adolescents is approximately 53.6%. The biometer, featuring real-time tomographic imaging capabilities, was independently developed over two years and has achieved 100% domestic production of its key components.